Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manoj B Charati

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Polymer Science. Part A, Polymer Chemistry|June 4, 2011
Elastomeric polypeptide-based biomaterialsLinqing Li, Manoj B Charati, Kristi L Kiick
Small (Weinheim an Der Bergstrasse, Germany)|July 7, 2010
Light-sensitive polypeptide hydrogel and nanorod compositesManoj B Charati, Ian Lee, Kolin C Hribar, et al.
Biomaterials|December 20, 2011
Injectable shear-thinning hydrogels engineered with a self-assembling Dock-and-Lock mechanismHoang D Lu, Manoj B Charati, Iris L Kim, et al.
Soft Matter|June 15, 2010
Hydrophilic elastomeric biomaterials based on resilin-like polypeptidesManoj B Charati, Jamie L Ifkovits, Jason A Burdick, et al.
Nature Materials|April 1, 2014
Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibitionBrendan P Purcell, David Lobb, Manoj B Charati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2020
Development of Highly Optimized Antibody-Drug Conjugates against CD33 and CD123 for Acute Myeloid LeukemiaYoon-Chi Han, Jennifer Kahler, Nicole Piché-Nicholas, et al.
Molecular Cancer Therapeutics|February 4, 2015
Tumor cells chronically treated with a trastuzumab-maytansinoid antibody-drug conjugate develop varied resistance mechanisms but respond to alternate treatmentsFrank Loganzo, Xingzhi Tan, Matthew Sung, et al.
Molecular Cancer Therapeutics|August 5, 2020
PF-06804103, A Site-specific Anti-HER2 Antibody-Drug Conjugate for the Treatment of HER2-expressing Breast, Gastric, and Lung CancersEdmund I Graziani, Matthew Sung, Dangshe Ma, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Polymer Science. Part A, Polymer Chemistry|June 4, 2011
Elastomeric polypeptide-based biomaterialsLinqing Li, Manoj B Charati, Kristi L Kiick
Small (Weinheim an Der Bergstrasse, Germany)|July 7, 2010
Light-sensitive polypeptide hydrogel and nanorod compositesManoj B Charati, Ian Lee, Kolin C Hribar, et al.
Biomaterials|December 20, 2011
Injectable shear-thinning hydrogels engineered with a self-assembling Dock-and-Lock mechanismHoang D Lu, Manoj B Charati, Iris L Kim, et al.
Soft Matter|June 15, 2010
Hydrophilic elastomeric biomaterials based on resilin-like polypeptidesManoj B Charati, Jamie L Ifkovits, Jason A Burdick, et al.
Nature Materials|April 1, 2014
Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibitionBrendan P Purcell, David Lobb, Manoj B Charati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2020
Development of Highly Optimized Antibody-Drug Conjugates against CD33 and CD123 for Acute Myeloid LeukemiaYoon-Chi Han, Jennifer Kahler, Nicole Piché-Nicholas, et al.
Molecular Cancer Therapeutics|February 4, 2015
Tumor cells chronically treated with a trastuzumab-maytansinoid antibody-drug conjugate develop varied resistance mechanisms but respond to alternate treatmentsFrank Loganzo, Xingzhi Tan, Matthew Sung, et al.
Molecular Cancer Therapeutics|August 5, 2020
PF-06804103, A Site-specific Anti-HER2 Antibody-Drug Conjugate for the Treatment of HER2-expressing Breast, Gastric, and Lung CancersEdmund I Graziani, Matthew Sung, Dangshe Ma, et al.
Pageof 1